Marknadsmeddelande 246/16 – Sista dag för handel med BTA i Nanologica AB

Sista dag för handel i bolagets betalda tecknade aktie, NICA BTA, är den 24 oktober 2016.

Information om betald tecknad aktie:

Kortnamn:	NICA BTA
ISIN-kod:	SE0009143381
Orderboks-ID:	126742
Sista handelsdag:	Den 24 oktober 2016

Stockholm den 19 oktober 2016

För mer information, vänligen kontakta AktieTorget på telefon 08-511 68 000 eller via

e-post info@aktietorget.se

Se marknadsmeddelande

See market notice

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.